Source comparison
BPC-157 Research Switching From Other Compounds: Comparison Table
TB-500 (Thymosin Beta-4) 20–24 hours 96 hours 7 days High. Both upregulate VEGF, promote angiogenesis, enhance fibroblast migration Requires longest washout due to persistent VEGF signaling; switching early confounds tissue repair attribution CJC-1295 DAC 6–8
This comparison does not assign a generated winner or score.
- TB-500 (Thymosin Beta-4)
- 20–24 hours
- 96 hours
- 7 days
- High. Both upregulate VEGF, promote angiogenesis, enhance fibroblast migration
- Requires longest washout due to persistent VEGF signaling; switching early confounds tissue repair attribution
- CJC-1295 DAC
- 6–8 days
- 10 days
- Indirect. Elevated IGF-1 enhances tissue repair independently of BPC-157
- Extended half-life and downstream GH effects necessitate full clearance to isolate BPC-157 outcomes
- CJC-1295 (non-DAC)
- 30 minutes
- 24 hours
- 48 hours
- Indirect. Transient GH pulse, minimal IGF-1 carryover
- Short half-life allows rapid transition; minimal risk of confounding
- Ipamorelin / GHRP-2
- 2 hours
- 72 hours
- None direct. GH secretagogue pathway separate from BPC-157 mechanisms
- Clean transition; washout primarily to normalize IGF-1, not for receptor competition
- GHK-Cu (Copper Peptide)
- 1–2 hours
- Minimal. GHK-Cu works through MMP modulation and collagen synthesis, not angiogenesis
- Lowest risk transition; mechanisms complementary rather than overlapping
- Melanotan II
- 33 minutes
- None. Melanocortin receptor agonism unrelated to BPC-157 pathways
- Standard plasma clearance sufficient; no mechanism interaction